Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells

被引:218
|
作者
SchmidtWolf, GD
Negrin, RS
SchmidtWolf, IGH
机构
[1] HUMBOLDT UNIV BERLIN,VIRCHOW CLIN,DEPT MED,DIV HEMATOL ONCOL,D-13353 BERLIN,GERMANY
[2] STANFORD UNIV,MED CTR,BONE MARROW TRANSPLANTAT PROGRAM,STANFORD,CA 94305
关键词
T cells; cytokine-induced killer cells; immunotherapy;
D O I
10.1007/s002770050257
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [1] Activated T cells and cytokine-induced CD3+CD56+ killer cells
    G. D. Schmidt-Wolf
    R. S. Negrin
    I. G. H. Schmidt-Wolf
    Annals of Hematology, 1997, 74 : 51 - 56
  • [2] MicroRNA profiling of CD3+CD56+ cytokine-induced killer cells
    Wang, Wenju
    Li, Ruhong
    Meng, Mingyao
    Wei, Chuanyu
    Xie, Yanhua
    Zhang, Yayong
    Jiang, Lihong
    Dong, Ruiyi
    Wang, Chunhui
    Zhong, Yiming
    Yang, Fang
    Tang, Weiwei
    Jin, Xingfang
    Liu, Baohua
    Hou, Zongliu
    SCIENTIFIC REPORTS, 2015, 5
  • [3] MicroRNA profiling of CD3+CD56+ cytokine-induced killer cells
    Wenju Wang
    Ruhong Li
    Mingyao Meng
    Chuanyu Wei
    Yanhua Xie
    Yayong Zhang
    Lihong Jiang
    Ruiyi Dong
    Chunhui Wang
    Yiming Zhong
    Fang Yang
    Weiwei Tang
    Xingfang Jin
    Baohua Liu
    Zongliu Hou
    Scientific Reports, 5
  • [4] 2 PATHWAYS OF EXOCYTOSIS OF CYTOPLASMIC GRANULE CONTENTS AND TARGET-CELL KILLING BY CYTOKINE-INDUCED CD3(+)CD56(+) KILLER-CELLS
    MEHTA, BA
    SCHMIDTWOLF, GH
    WEISSMAN, IL
    NEGRIN, RS
    BLOOD, 1995, 86 (09) : 3493 - 3499
  • [5] Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells
    Valgardsdottir, Rut
    Capitanio, Cristina
    Texido, Gemrna
    Pende, Daniela
    Cantoni, Claudia
    Pesenti, Enrico
    Rambaldi, Alessandro
    Golay, Josee
    Introna, Martino
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (12) : 1013 - 1021
  • [6] Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease
    Jabir, Nasimudeen R.
    Firoz, Chelapram K.
    Ahmed, Farid
    Kamal, Mohammad A.
    Hindawi, Salwa
    Damanhouri, Ghazi A.
    Almehdar, Hussein A.
    Tabrez, Shams
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (05) : 526 - 535
  • [7] Generation of CD3+CD56+ Cytokine-Induced Killer Cells and Their In Vitro Cytotoxicity against Pediatric Cancer Cells
    Suradej Hongeng
    Sawang Pctviscs
    Surapon Worapongpaiboon
    Busaba Rcrkamnuaychoke
    Samart Pakakasama
    Saengsuree Jootar
    International Journal of Hematology, 2003, 77 : 175 - 179
  • [8] In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gamma delta T cells from glioblastoma patients
    Fujimiya, Y
    Suzuki, Y
    Katakura, R
    Miyagi, T
    Yamaguchi, T
    Yoshimoto, T
    Ebina, T
    CLINICAL CANCER RESEARCH, 1997, 3 (04) : 633 - 643
  • [9] Functional properties of clonal populations of CD3(+)CD56(+) cells
    Lu, PH
    Wang, ZH
    Negrin, RS
    BLOOD, 1996, 88 (10) : 2896 - 2896
  • [10] Generation of CD3+CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer
    Hongeng, S
    Petvises, S
    Worapongpaiboon, S
    Rerkamnuaychoke, B
    Pakakasama, S
    Jootar, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (02) : 175 - 179